the RT2831 project of Regenecore officially o↑¶→btained IND approval by F≥∞DA
- Categories:News
- Author:
- Origin:
- Time of issue:2024-07-26
- Views:0
the RT2831 project o ₩f Regenecore officially obtained IND £™&☆approval by FDA
(Summary description)On July 25th, the RT2831 project of Nanji↑±✘ng Regenecore officially obtained Investigatioδα≈nal New Drug Application (IND) approval by FD✘γ≤↔A, USA. This is another major breakthrough fo∑←•r the Regenecore team in the field of tum↑₩ or treatment after autoimmune di<α÷seases, and also the second IND approv©∞¥<al for nanobody drugs obtaineλ✔✘d by the Regenecore team.
- Categories:News
- Author:
- Origin:
- Time of issue:2024-07-26
- Views:0
On July 25th, the RT2831 proje&✘♦ct of Nanjing Regene÷"γcore officially obta ☆ined Investigational New Drug Application (•↓IND) approval by FDA, USA. This is aλγnother major breakthrough for©£'γ the Regenecore team in the field of t€±umor treatment after ™πautoimmune diseases, and also the se<βcond IND approval for nanobod§ε≠<y drugs obtained by the Regenec↑"βore team.
Regenecore will contin"λ→♣ue to increase research and development investm&₩∏♣ent, promote the RT2831 project to achieve more p♦↓β→ositive results in clinical ÷☆¶research, and bring more ¥↕&blessings to cancer patients. At the same time, Wα✘↕e will actively explo≠↔₩€re more innovative drugs and continue to moπδ ve forward firmly on the path of &q←βuot;maintaining human health with excellent drugs±×↓".
Scan the QR code to read on your phone
TEL：
Address: Room 07 Building 1↕£6 Treehouse, No. 73, Tanmi Road, σ£&Jiangbei New District® &, Nanjing
Enterprise email：rjk@regenecore.com
WeChat cooperative consultation
You are the th visitor
025-58608860 
Contact 